MiniMed Group, Inc. (MMEDV) vs Monopar Therapeutics Inc. (MNPR)

A side-by-side comparison of MiniMed Group, Inc. and Monopar Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MMEDV

MiniMed Group, Inc.

$560M

$20.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

MNPR

Monopar Therapeutics Inc.

$533M

$79.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MMEDV vs MNPR

growth of $100 · dividends reinvested · last 1y

MMEDV +7.0% (+7.0%/yr)MNPR +0.4% (+0.4%/yr)MMEDV compounded faster over this window

MMEDV MNPR

Metrics side by side

Total return (annualized)

Metric	MMEDV	MNPR
Total return (1Y)	N/A	-21.14%
Total return CAGR (3Y)	N/A	205.27%
Total return CAGR (5Y)	N/A	27.38%

MMEDV is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full MMEDV analysis Full MNPR analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.